{"id":"W4412389942","doi":"10.3390/ijms26146699","title":"A Novel Chemotherapy Combination to Enhance Proteotoxic Cell Death in Hepatocellular Carcinoma Experimental Models Without Killing Non-Cancer Cells","year":2025,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"NAEJA-RGM Pharmaceuticals (Canada)","funders":"State of Florida; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Ixazomib; Cancer research; Cancer cell; Proteasome inhibitor; Programmed cell death; Biology; Cancer; Hepatocellular carcinoma; Apoptosis; Proteasome; Cell biology; Carfilzomib; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004643727,0.0001294546,0.0001353397,0.0002409175,0.00005523039,0.00008427969,0.0007501938,0.00006618695,0.000008203537],"category_scores_gemma":[0.00003063629,0.0001288037,0.0001004234,0.0001895959,0.00008300971,0.00002547964,0.0000948815,0.00009453345,8.743884e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001104445,"about_ca_system_score_gemma":0.0004836254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006245674,"about_ca_topic_score_gemma":0.000003512821,"domain_scores_codex":[0.9986373,0.00004533423,0.0003324052,0.0002787971,0.000525422,0.0001807881],"domain_scores_gemma":[0.9992841,0.00001046994,0.0001919475,0.0001175304,0.0003149646,0.00008091347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001446846,0.0002813308,0.007950014,0.000005712861,0.00002601637,0.00002158545,0.000247117,0.01181898,0.9790776,0.0001087162,0.000025758,0.0002924539],"study_design_scores_gemma":[0.0007441826,0.0002076599,0.0002780765,0.0001331209,0.00000610864,0.000005332471,0.0001042369,0.008594958,0.9894506,0.0002439615,0.0001046441,0.0001271255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8633394,0.0009073426,0.1343868,0.0003805415,0.0004377787,0.0002426914,0.000004677477,0.000002552826,0.0002982326],"genre_scores_gemma":[0.9900173,0.00005139422,0.00893242,0.0008014939,0.00007522519,0.00003493907,0.000002032126,0.00001040261,0.00007479702],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1266779,"threshold_uncertainty_score":0.5252462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.015905010530558,"score_gpt":0.313582414941916,"score_spread":0.297677404411358,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}